Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 53 Records) |
| Query Trace: Disease and U2AF1[original query] |
|---|
| High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG). Cancers 2020 8 12 (8): . Salmoiraghi Silvia, Cavagna Roberta, Zanghì Pamela, Pavoni Chiara, Michelato Anna, Buklijas Ksenija, Elidi Lara, Intermesoli Tamara, Lussana Federico, Oldani Elena, Caprioli Chiara, Stefanoni Paola, Gianfaldoni Giacomo, Audisio Ernesta, Terruzzi Elisabetta, De Paoli Lorella, Borlenghi Erika, Cavattoni Irene, Mattei Daniele, Scattolin Annamaria, Tajana Monica, Ciceri Fabio, Todisco Elisabetta, Campiotti Leonardo, Corradini Paolo, Fracchiolla Nicola, Bassan Renato, Rambaldi Alessandro, Spinelli Oriet |
| Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis. Clinical lymphoma, myeloma & leukemia 2020 8 20 (12): e956-e960. Castillo-Tokumori Franco, Talati Chetasi, Al Ali Najla, Sallman David, Yun Seongseok, Sweet Kendra, Padron Eric, Lancet Jeffrey, Komrokji Rami, Kuykendall Andrew |
| Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse. Haematologica 2020 8 106 (9): 2325-2333. Onecha Esther, Rapado Inmaculada, Luz Morales María, Carreño-Tarragona Gonzalo, Martinez-Sanchez Pilar, Gutierrez Xabier, Sáchez Pina José María, Linares María, Gallardo Miguel, Martinez-López Joaquín, Ayala Ro |
| Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood advances 2020 May 4 (9): 1942-1949. Gardin Claude, Pautas Cécile, Fournier Elise, Itzykson Raphaël, Lemasle Emilie, Bourhis Jean-Henri, Adès Lionel, Marolleau Jean-Pierre, Malfuson Jean-Valère, Gastaud Lauris, Raffoux Emmanuel, Lambert Juliette, Braun Thorsten, Thomas Xavier, Chantepie Sylvain, Cluzeau Thomas, de Botton Stéphane, Berthon Céline, Boissel Nicolas, Duployez Nicolas, Terré Christine, Peffault de Latour Régis, Michallet Mauricette, Celli-Lebras Karine, Preudhomme Claude, Dombret Her |
| Identification of acquired PIGA mutations and additional variants by next-generation sequencing in paroxysmal nocturnal hemoglobinuria. International journal of laboratory hematology 2020 5 42 (4): 473-481. Li Jing, Lin Yani, Chen Long, Qin Li, Tan Hao, Zou Junyan, Zhang Donglei, Nie Yanbo, Wang Guangjuan, Zhang Hong, Liu Enbin, Chen Xuejing, Ru K |
| [Clinical analysis of gene mutation characteristics and mutation burden in myelodysplastic syndrome]. Zhonghua yi xue za zhi 2020 4 100 (12): 933-937. Lü X D, Li Y W, Guo Z, Xin Y P, Hu J Y, Fan R H, Song Y |
| [Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 2004-2010. Cen Yan-Xia, Li Y |
| Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome. Scientific reports 2020 10 10 (1): 18622. Wang Haiqiong, Guo Yongbo, Dong Zhenkun, Li Tao, Xie Xinsheng, Wan Dingming, Jiang Zhongxing, Yu Jifeng, Guo Ro |
| CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Annals of hematology 2021 Apr . Qian Yi, Chen Yan, Li Xiaomi |
| Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology. International journal of molecular sciences 2021 Mar 22 (5): . Karantanos Theodoros, Jain Tania, Moliterno Alison R, Jones Richard J, DeZern Amy |
| Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax. Blood advances 2021 Apr 5 (8): 2173-2183. Lachowiez Curtis A, Loghavi Sanam, Furudate Ken, Montalban-Bravo Guillermo, Maiti Abhishek, Kadia Tapan, Daver Naval, Borthakur Gautam, Pemmaraju Naveen, Sasaki Koji, Alvarado Yesid, Yilmaz Musa, Short Nicholas J, Chien Kelly, Ohanian Maro, Pierce Sherry, Patel Keyur P, Jabbour Elias, Ravandi Farhad, Kantarjian Hagop M, Garcia-Manero Guillermo, Takahashi Koichi, Konopleva Marina Y, DiNardo Courtney |
| Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome. Frontiers in oncology 2020 10 610525. Fang Ying, Guo Juan, Wu Dong, Wu Ling-Yun, Song Lu-Xi, Zhang Zheng, Zhao You-Shan, Chang Chun-Ka |
| Bioinformatics analysis of high frequency mutations in myelodysplastic syndrome-related patients. Annals of translational medicine 2021 11 9 (19): 1491. Wu Kun, Nie Bo, Li Liyin, Yang Xin, Yang Jinrong, He Zhenxin, Li Yanhong, Cheng Shenju, Shi Mingxia, Zeng Y |
| Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression. European journal of haematology 2021 1 106 (4): 520-528. Bartels Stephan, Vogtmann Julia, Schipper Elisa, Büsche Guntram, Schlue Jerome, Lehmann Ulrich, Kreipe Ha |
| NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1. Leukemia research 2022 5 118 106869. Zhao Davidson, Zarif Mojgan, Eladl Entsar, Capo-Chichi José-Mario, Smith Adam C, Atenafu Eshetu G, Tierens Anne, Minden Mark D, Schuh Andre, Chang Ho |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific reports 2022 4 12 (1): 5925. Maurya Nehakumari, Mohanty Purvi, Dhangar Somprakash, Panchal Purvi, Jijina Farah, Mathan S Leo Prince, Shanmukhaiah Chandrakala, Madkaikar Manisha, Vundinti Babu R |
| Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials. Haematologica 2022 11 . González-Gil Celia, Morgades Mireia, Lopes Thaysa, Fuster-Tormo Francisco, García-Chica Jesús, Zhao Ran, Montesinos Pau, Torrent Anna, Diaz-Beya Marina, Coll Rosa, Hermosín Lourdes, Mercadal Santiago, González-Campos José, Zamora Lurdes, Artola Teresa, Vall-Llovera Ferran, Tormo Mar, Gil-Cortés Cristina, Barba Pere, Novo Andrés, Ribera Jordi, Bernal Teresa, De Ugarriza Paula López, Queipo María-Paz, Martínez-Sánchez Pilar, Giménez Alicia, González-Martínez Teresa, Cladera Antonia, Cervera José, Fernández-Martín Rosa, Ardaiz María Ángeles, Vidal María Jesús, Baena Ángela, López-Bigas Nuria, Bigas Anna, Maciejewski Jaroslaw, Orfao Alberto, Ribera Josep Maria, Genescà Eulal |
| Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological oncology 2022 11 . Lee Wan-Hsuan, Lin Chien-Chin, Wang Yu-Hung, Yao Chi-Yuan, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Hsu Cheng-An, Sun Hsun-I, Chuang Yi-Kuang, Hsu Chia-Lang, Tien Feng-Ming, Tsai Cheng-Hong, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
| U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
| Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile. Annals of hematology 2023 8 . Luca Guarnera, Emiliano Fabiani, Cristina Attrotto, Hajro Hajrullaj, Antonio Cristiano, Roberto Latagliata, Susanna Fenu, Francesco Buccisano, Maria Irno-Consalvo, Consuelo Conti, Maria Teresa Voso, Luca Mauril |
| The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis. Frontiers in oncology 2023 8 13 1190305. Helna Pettersson, Jenni Adamsson, Peter Johansson, Staffan Nilsson, Lars Palmqvist, Björn Andréasson, Julia A |
| The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms. British journal of haematology 2023 5 . Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, Rami Basmaci, Bahga Katamesh, Patricia Greipp, James M Foran, Talha Badar, Abhishek A Mangaonkar, Kebede H Begna, Naseema Gangat, Mrinal M Patnaik, Mark R Litzow, Mithun V Shah, David S Viswanatha, Rong He, Hassan B Alkhateeb, Aref Al-Ka |
| Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology 2023 5 81 (20): 1996-2009. Esra D Gumuser, Art Schuermans, So Mi Jemma Cho, Zachary A Sporn, Md Mesbah Uddin, Kaavya Paruchuri, Tetsushi Nakao, Zhi Yu, Sara Haidermota, Whitney Hornsby, Lachelle D Weeks, Abhishek Niroula, Siddhartha Jaiswal, Peter Libby, Benjamin L Ebert, Alexander G Bick, Pradeep Natarajan, Michael C Honigbe |
| Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms. Leukemia & lymphoma 2023 11 1-10. Steven M Johnson, James Haberberger, Jonathan Galeotti, Lori Ramkissoon, Catherine C Coombs, Daniel R Richardson, Matthew C Foster, Daniel Duncan, Nathan D Montgomery, Naomi L Ferguson, Joshua F Zeidn |
| Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
| Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype. Annals of hematology 2024 9 . Nanfang Huang, Chunkang Chang, Lingyun Wu, Qi He, Zheng Zhang, Xiao Li, Feng |
| The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study. Leukemia & lymphoma 2024 8 1-10. Deyuan Hu, Kai Shen, YuSha Guo, Xie Bing Bao, Ningzheng Dong, Suning Ch |
| A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related. International journal of laboratory hematology 2024 4 . Dong Chen, Julia Geyer, Adam Bagg, Robert Hasserjian, Olga K Weinbe |
| Pre-Transplant Chromosome Genomic Array Testing Improves Prognosis for Myelofibrosis Patients Undergoing Transplantation. Transplantation and cellular therapy 2024 12 . Xiaoyu Qu, Emily Stevens, Matthew P Fitzgibbon, Lan Beppu, Tim M Monahan, Cecilia Yeung, Derek L Stirewalt, David Wu, Jerald P Radich, H Joachim Deeg, Min Fa |
- Page last reviewed:Feb 1, 2024
- Content source: